These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 7808021

  • 21. Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group.
    Paredes J, Kahn JO, Tong WP, Feldstein ML, Lin S, Bennett JM, Metroka CE, Ratner L, Krown SE.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun 01; 9(2):138-44. PubMed ID: 7749790
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcoma.
    Lim ST, Tupule A, Espina BM, Levine AM.
    Cancer; 2005 Jan 15; 103(2):417-21. PubMed ID: 15578686
    [Abstract] [Full Text] [Related]

  • 24. Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma.
    Bihl F, Berger C, Chisholm JV, Henry LM, Bertisch B, Trojan A, Nadal D, Speck RF, Flepp M, Brander C, Mueller NJ, Swiss HIV Cohort Study.
    AIDS; 2009 Sep 10; 23(14):1918-22. PubMed ID: 19609199
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma.
    Gill PS, McLaughlin T, Espina BM, Tulpule A, Louie S, Lunardi-Iskandar Y, Gallo RC.
    J Natl Cancer Inst; 1997 Dec 03; 89(23):1797-802. PubMed ID: 9392621
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Continuous infusion etoposide in advanced AIDS-related kaposi sarcoma.
    Remick SC, Reddy M, Ekman K, Vyzula R, Hilstro J, Horton J.
    J Infus Chemother; 1996 Dec 03; 6(2):92-6. PubMed ID: 8809657
    [Abstract] [Full Text] [Related]

  • 32. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS.
    Krown SE, Paredes J, Bundow D, Polsky B, Gold JW, Flomenberg N.
    J Clin Oncol; 1992 Aug 03; 10(8):1344-51. PubMed ID: 1634925
    [Abstract] [Full Text] [Related]

  • 33. Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma.
    Aboulafia D, Miles SA, Saks SR, Mitsuyasu RT.
    J Acquir Immune Defic Syndr (1988); 1989 Aug 03; 2(1):54-8. PubMed ID: 2918461
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".
    Volkow P, Zinser JW, Correa-Rotter R.
    BMC Nephrol; 2007 Mar 27; 8():6. PubMed ID: 17386117
    [Abstract] [Full Text] [Related]

  • 36. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.
    Gill PS, Tulpule A, Espina BM, Cabriales S, Bresnahan J, Ilaw M, Louie S, Gustafson NF, Brown MA, Orcutt C, Winograd B, Scadden DT.
    J Clin Oncol; 1999 Jun 27; 17(6):1876-83. PubMed ID: 10561228
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.